ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Frailty, urinary symptoms, comorbidity and multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Article
- Letter to the Editor "Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis".Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrinary symptoms represent a significant source of distress and disability in multiple sclerosis (MS), but the factors influencing their occurrence and exacerbation remain unclear. Frailty has been proposed as a measure of clinical complexity in MS and has been associated with its main phenotypic manifestations. The present study investigated the relationship between frailty and the presence and burden of urinary symptoms in MS. MATERIALS AND
methodsThe present study considered 149 outpatients. The presence of urinary symptoms was systematically explored. Frailty was assessed using a 40-item Frailty Index (FI). Participants with urinary symptoms underwent a urinary evaluation, including the 8-item overactive bladder questionnaire, the Urinary Incontinence Quality of Life Scale, Uroflowmetry, and Ultrasound for Postvoid Residual.
resultsThe mean disease duration was 13.7 years (SD 10.5), the median EDSS score was 1.5 (IQR = 0-3). Frailty was significantly associated with the presence and burden of urinary symptoms. Additionally, there was a positive correlation between the frailty index and chronological age, EDSS, disease duration, OAB, and I-QOL (all p < 0.05). In people with urinary symptoms, two multivariable logistic regression models showed that only the frailty index score was significantly associated with the Incontinence Quality of Life Scale total score and the 8-item overactive bladder questionnaire. No correlations were found between uroflowmetry data, postvoid residual, and frailty.
conclusionFrailty is associated with the presence and burden of disability due to urinary symptoms. Frailty possibly affects the pathophysiological mechanisms of MS involved in the development and worsening of urinary symptoms.
Indexed as
Identifiers
40100557What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.